Royal London Hospital
London, E1 1FR, United Kingdom
NCT Number: NCT05206760
Safety and feasibility study investigating brain biopsy in severe head injury. When a patient undergoes craniotomy or ICP bolt insertion for trauma, a biopsy of brain tissue is taken.
Blood, saliva, urine and faeces samples are also taken for 7 days following the brain biopsy.
CSF is collected if a CSF drainage device is used.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
London, E1 1FR, United Kingdom
A minor amendment was submitted to allow histological and immunohistochemical analysis of the samples.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Severe traumatic brain injury -
Exclusion criteria
Coagulopathy
-
Biopsy of brain tissue
Time frame: immediately after the intervention/procedure/surgery
Is it feasible to perform brain biopsy through ICP bolt or at time of craniotomy in TBI in order to obtain diagnostic tissue?
Time frame: immediately after the intervention/procedure/surgery
Is it safe to perform brain biopsy through ICP bolt or at time of craniotomy in TBI?
Time frame: immediately after the intervention/procedure/surgery
Classify TBI based on histopathological appearances
Queen Mary University of London
Other
Acronym: SHIBA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03810222
Brain Diseases, Brain Injuries
Bergamo, Italy
View Trial DetailsNCT06480838
Brain Diseases, Brain Injuries
Dallas, Texas, United States
View Trial DetailsNCT04331392
Behavior, Brain Damage, Chronic
Toronto, Ontario, Canada
View Trial DetailsNCT05038930
Brain Diseases, Brain Injuries
Copenhagen, Denmark
View Trial Details